Seeking Advice on Lu-177 PSMA Therapy vs. Carboplatin Chemo

Hi everyone,

I'm reaching out for some guidance and shared experiences. My father (55) was diagnosed with advanced metastatic prostate cancer at the end of 2019. Since then, he's undergone a radical prostatectomy followed by various treatments including hormone therapy, radiotherapy, chemotherapy, and clinical trials. Unfortunately, the most recent (his second) round of chemotherapy has stopped working, and his doctor has informed us that all traditional therapy options have been exhausted.

The doctor has now recommended starting carboplatin chemotherapy next Monday. However, during my research, I came across Lu-177 PSMA therapy, which seems to offer promising results for cases like my father's. The catch is that Lu-177 PSMA is neither funded nor available in our country, but we might be able to afford the 4-6 recommended cycles in another EU country.

Has anyone here had experience with Lu-177 PSMA therapy? How does it compare to carboplatin chemotherapy in terms of efficacy and side effects? We are very much considering this option and would appreciate any insights or personal experiences you could share.

Thank you in advance for your help and support.